4:45 PM - 6:45 PM

[3P1117] Elevated β-catenin pathway as a novel target for patients with resistance to EGF　receptor targeting drugs

〇Asuka Nakata¹, Ryo Yoshida², Rui Yamaguchi³, Yoshinori Tamada⁴, Andre Fujita⁴, Teppei Shimamura⁴, Seiya Imoto⁴, Tomoyuki Higuchi², Masaharu Nomura⁵, Tatsuo Kimura⁶, Hiroshi Nokihara⁷, Masahiko Higashiyama⁸, Kazuya Kondoh⁹, Hiroshi Nishihara¹⁰, Arinobu Tojo¹¹, Seiji Yano¹², Satoru Miyano^3,4, Noriko Gotoh¹ (1.Div. of Cancer Cell Biol., Cancer Res. Inst., Kanazawa Univ., 2.Inst. of Statistical Mathematics, 3.Sequence Analysis, Inst. of Med. Sci., Univ. of Tokyo, 4.DNA information Analysis, Inst. of Med. Sci., Univ. of Tokyo, 5.Hosp. 1st. Dept. of Surg., Tokyo Med. Univ., 6.Osaka City Univ., 7.Natl. Cancer Ctr. Hosp., 8.Osaka Medical Center for Cancer and Cardiovascular Diseases, 9.The Univ. of Tokushima Grad. Sch., 10.Hokkaido Univ. Grad. Sch. of Med., 11.Div. of Mol. Therapy, Inst. of Med. Sci., Univ. of Tokyo, 12.Div. of Med. Oncol., Cancer Res. Inst., Kanazawa Univ.)

肺がん, EGFR-TKIs